There are 2789 resources available
New targets in ovarian cancer
Presenter: David SP Tan
Session: Molecular-driven therapy in ovarian cancer
Resources:
Slides
Webcast
Combinations with immune therapy in ovarian cancer
Presenter: Florence Joly Lobbedez
Session: Molecular-driven therapy in ovarian cancer
Resources:
Slides
Webcast
Introduction
Presenter: Lena Specht
Session: Long-term side effects in the treatment of lymphoma
Resources:
Slides
Webcast
Introduction
Presenter: Carlos Barrios
Session: Next generation therapies in metastatic breast cancer
Resources:
Webcast
Emerging targets in metastatic breast cancer: What have we learnt from molecular analysis?
Presenter: Sherene Loi
Session: Next generation therapies in metastatic breast cancer
Resources:
Slides
Webcast
New generation antibody drug conjugates (ADCs)
Presenter: Ian Krop
Session: Next generation therapies in metastatic breast cancer
Resources:
Slides
Webcast
Expanding indications of DNA damage agents
Presenter: Andrew Tutt
Session: Next generation therapies in metastatic breast cancer
Resources:
Slides
Webcast
What comes after anti-PD1?
Presenter: Giuseppe Curigliano
Session: Next generation therapies in metastatic breast cancer
Resources:
Slides
Webcast
Introduction
Presenter: Leila Akkari
Session: Next frontiers or new players in immuno-oncology
Resources:
Slides
Webcast
Myeloid cell mediated resistance to immune therapy
Presenter: Leila Akkari
Session: Next frontiers or new players in immuno-oncology
Resources:
Slides
Webcast